Alex Hlavaty

Grenoble, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Correction to: Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.

Correction to: Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.

Journal: Circulation

Published: May 26, 2026

Reply to "A Comment about AI Methods that May Help Advance Pharmacovigilance".

Reply to "A Comment about AI Methods that May Help Advance Pharmacovigilance".

Journal: Clinical pharmacology and therapeutics

Published: April 17, 2026

Redundant pharmacovigilance disproportionality analyses: Navigating between Scylla and Charybdis.

Redundant pharmacovigilance disproportionality analyses: Navigating between Scylla and Charybdis.

Journal: Headache

Published: April 06, 2026

Changes in estimands and prevalence of discrepancies in conclusions under the two-trial paradigm: a systematic review.

Changes in estimands and prevalence of discrepancies in conclusions under the two-trial paradigm: a systematic review.

Journal: Journal of clinical epidemiology

Published: March 24, 2026

Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design.

Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design.

Journal: Circulation

Published: February 12, 2026

Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.

Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.

Journal: Circulation

Published: January 28, 2026

Validation of in-hospital diagnosis codes to identify skin ulcers in healthcare databases: A correspondence. Response of authors.

Validation of in-hospital diagnosis codes to identify skin ulcers in healthcare databases: A correspondence. Response of authors.

Journal: Therapie

Published: December 01, 2025

Fenfluramine-associated pulmonary hypertension: a study of adverse events reporting system FAERS.

Fenfluramine-associated pulmonary hypertension: a study of adverse events reporting system FAERS.

Journal: ERJ open research

Published: November 18, 2025

The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence-Based Medicine.

The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence-Based Medicine.

Journal: Clinical pharmacology and therapeutics

Published: November 04, 2025

Drug-Induced Raynaud's Phenomenon and Underlying Mechanism: A Disproportionality Analysis From the World Health Organization Pharmacovigilance Database.

Drug-Induced Raynaud's Phenomenon and Underlying Mechanism: A Disproportionality Analysis From the World Health Organization Pharmacovigilance Database.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: July 24, 2025

Respiratory Disorders Associated with Antibody-Drug Conjugates: A Combined Analysis of the French and the WHO Pharmacovigilance Databases.

Respiratory Disorders Associated with Antibody-Drug Conjugates: A Combined Analysis of the French and the WHO Pharmacovigilance Databases.

Journal: Clinical pharmacology and therapeutics

Published: July 09, 2025

Detection and Evaluation of Drug-associated Pulmonary Arterial Hypertension.

Detection and Evaluation of Drug-associated Pulmonary Arterial Hypertension.

Journal: American journal of respiratory and critical care medicine

Published: June 12, 2025

Showing 1-12 of 25

Last Updated: 09/26/2026